![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Author: Pardi D.S. Loftus Jr E.V. Camilleri M.
Publisher: Adis International
ISSN: 1170-229X
Source: Drugs & Aging, Vol.19, Iss.5, 2002-05, pp. : 355-363
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Inflammatory Bowel Disease in the Elderly
Drugs & Aging, Vol. 27, Iss. 8, 2010-08 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Mesalazine for the treatment of inflammatory bowel disease
Expert Opinion on Pharmacotherapy, Vol. 14, Iss. 12, 2013-08 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Thiopurine Treatment in Inflammatory Bowel Disease
Clinical Pharmacokinetics, Vol. 46, Iss. 9, 2007-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Pharmacokinetic Considerations in the Treatment of Inflammatory Bowel Disease
Clinical Pharmacokinetics, Vol. 40, Iss. 10, 2001-01 ,pp. :